ArticleBMJ open2026

Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial.

Laura Cristoferi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.